Sexually Transmitted Infections Clinical Trials Group: Phase 2 Clinical Trial to Evaluate a Vaccine Candidate for Neisseria Gonorrhoeae

性传播感染临床试验组：评估淋病奈瑟菌候选疫苗的 2 期临床试验

• 批准号: 10019173
• 负责人: JEANNE M MARRAZZO
• 金额: $ 353.27万
• 依托单位: UNIVERSITY OF ALABAMA AT BIRMINGHAM
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-09-06 至 2021-09-05
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10019173
• 关键词: Bacterial Drug Resistance; Biological; Clinical Research; Clinical Trials; Clinical Trials Cooperative Group; Human Resources; Infrastructure; Laboratories; Leadership; Neisseria gonorrhoeae; Phase II Clinical Trials; Sexually Transmitted Diseases; Training; clinical research site; experience; gonorrhea vaccine; protocol development; sample collection; vaccine candidate

The Sexually Transmitted Infections Clinical Trials Group provides infrastructure to conduct sexually transmitted infections (STIs) related clinical research, including providing clinical sites, trained and experienced personnel, laboratories, protocol development, clinical trial coordination, biological sample collection, storage, scientific leadership, and other aspects related to the conduct of clinical studies.

性传播感染临床试验小组提供了进行性传播感染（STIS）相关临床研究的基础设施，包括提供临床部位，训练和经验丰富的人员，实验室，协议开发，临床试验协调，生物样本收集，存储，科学领导，科学领导，科学领导，以及科学领导力以及科学领导力以及与临床研究的进行有关的其他方面。